|
Recruiting
|
NCT01432847 -
Cell Collection to Study Eye Diseases
|
|
|
Recruiting
|
NCT03893474 -
Quality-Assured Follow-up of Quiescent Neovascular Age -Related maculaR dEgeneration by Non-medical Practitioners
|
N/A |
|
Completed
|
NCT00971464 -
Low Vision Study Comparing EV Training vs. CCTV for AMD Rehabilitation
|
Phase 2 |
|
Terminated
|
NCT00332657 -
Anecortave Acetate Risk Reduction Trial (AART)
|
Phase 3 |
|
Recruiting
|
NCT04796545 -
Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration
|
N/A |
|
Completed
|
NCT01766596 -
Study the Signs of Ocular Degeneration in a Population Cohort (Dijon 3C Montrachet Cohort)
|
N/A |
|
Completed
|
NCT03322930 -
Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)
|
|
|
Completed
|
NCT01778491 -
AMD Phenotype and Genotype Study
|
|
|
Completed
|
NCT01016873 -
INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD
|
Phase 2 |
|
Active, not recruiting
|
NCT03845582 -
Phase 3 Study of ALK-001 in Geographic Atrophy
|
Phase 3 |
|
Completed
|
NCT03372746 -
Generation of Induced Pluripotent Stem (iPS) Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular Degeneration
|
|
|
Completed
|
NCT03367767 -
Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-On
|
|
|
Terminated
|
NCT00333216 -
Anecortave Acetate Risk-Reduction Trial (AART)
|
Phase 3 |
|
Completed
|
NCT01570790 -
Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration
|
Phase 1/Phase 2 |
|
Completed
|
NCT00346866 -
Anecortave Acetate Versus Placebo in AMD Patients Following PDT
|
Phase 2 |
|
Withdrawn
|
NCT00726466 -
Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration
|
Phase 1 |
|
Completed
|
NCT00306488 -
OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration
|
Phase 2 |
|
Terminated
|
NCT02348359 -
X-82 to Treat Age-related Macular Degeneration
|
Phase 2 |
|
Completed
|
NCT01632527 -
Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)
|
Phase 1/Phase 2 |
|
Withdrawn
|
NCT01339949 -
Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)
|
N/A |